A simple blood test is transforming the world of prenatal screening, offering women a risk-free way to learn about fetal abnormalities early in pregnancy. Already, the new test has drastically reduced ...

Vancouver, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The global amniocentesis needle market size was USD 172.8 Million in 2022 and is expected to register a rapid revenue CAGR of 2.8% during the forecast ...

When Amy Seitz got pregnant with her second child last year, she knew that being 35 years old meant there was an increased chance of chromosomal disorders like Down syndrome. She wanted to be screened ...

Is simply being 35 or older enough reason for a pregnant woman to undergo amniocentesis to check for Down syndrome? The older mothers-to-be are, the higher their risk of having babies with this fairly ...

Building on the latest developments in DNA science, Stanford University researchers have designed a prenatal genetic test that appears to be just as accurate — but much safer than current methods like ...

I remember 15 years ago, my colleagues and I in high risk obstetrics were discussing the future possibility of analyzing fetal cells in maternal blood. Back then, the task seemed daunting since there ...

Imagine a window into the womb, a portal that allows us to peek into the intricate world of foetal development. Amidst the joy and anticipation, concerns about the health and well-being of their ...

A California company hopes to take the needles — and risk — out of prenatal genetic testing. Each year, about 200,000 amniocentesis tests are performed, according to the Mayo Clinic, most during the ...

One rainy afternoon a year ago, I sat numbly by the phone, waiting for the hospital midwife to ring and tell me the result of an amniocentesis test, and thus whether my unborn child had Down’s ...